• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Coherus Biosciences, Inc. (CHRS)

    -NasdaqGM
    31.59 Down 1.11(3.39%) Feb 27, 4:00PM EST
    |After Hours : 31.58 Down 0.01 (0.02%) Feb 27, 4:36PM EST
    Add to Portfolio
    Prev Close:32.70
    Open:32.58
    Bid:27.02 x 100
    Ask:N/A
    1y Target Est:7.35
    Beta:1.71
    Next Earnings Date:N/A
    Day's Range:30.60 - 32.78
    52wk Range:12.38 - 33.16
    Volume:152,294
    Avg Vol (3m):192,852
    Market Cap:1.05B
    P/E (ttm):N/A
    EPS (ttm):-3.86
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):42.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Jan-13) :N/A
    Quarterly EPS Est (Jul-12) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Coherus Biosciences, Inc., a late-stage clinical biologics platform company, focuses on developing and commercializing biosimilar products worldwide. Its clinical stage pipeline consists of CHS-0214, an etanercept biosimilar candidate, which is in... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback